journal article·2008-01

Synthesis and colon-specific drug delivery of a poly(acrylic acid-co-acrylamide)/MBA nanosized hydrogel

Debajyoti Ray, Dillip K. Mohapatra, Ranjit K. Mohapatra, Guru P. Mohanta, Prafulla K. Sahoo

Publisher page

Abstract

Intravenous administration of 5-fluorouracil (5-FU) for colon cancer therapy produces severe systemic side-effects due to its cytotoxic effect on normal cells. The main objective of the present study was to develop novel oral site-specific delivery of 5-FU to the colon with less drug being released in the stomach or small intestine using biodegradable hydrogel, hydrogel nanoparticles and comparing the targeting efficiency of 5-FU to colon from both. Poly(acrylic acid-co-acrylamide) (P(AA-co-Am)) normal hydrogel and hydrogel nanoparticles (HN) were synthesized by free radical polymerization using N,N-methylene-bis-acrylamide (MBA) as cross-linker, potassium persulfate as reaction initiator and 5-FU was loaded. HN were found to be degradable in physiological medium and showed comparatively higher swelling in rat caecal medium (RCM). 5-FU entrapment was increased by increasing Am (wt%) monomer feed. In vitro release of 5-FU from normal hydrogel and HN in pH progressive medium, it was found that a AA/Am ratio of 25:75 showed higher release in RCM. The Higuchi model yielded good adjustment of in vitro release kinetics. A higher amount of 5-FU reached the colon in HN (61 +/- 2.1%) than normal hydrogel (40 +/- 3.6%) by organ biodistribution studies in albino rats.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Hydrogels: synthesis, properties, applications · Nanoparticle-Based Drug Delivery · Drug Solubulity and Delivery Systems

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

a P.G. Department of Pharmaceutics, Sri Jayadev College of Pharmaceutical Sciences, Naharakanta, Bhubaneswar 752101, India

b University Department of Pharmaceutical Sciences, Utkal University, Bhubaneswar 751004, India

c University Department of Pharmaceutical Sciences, Utkal University, Bhubaneswar 751004, India

d Department of Pharmacy, Annamalai University, Annamalai nagar, Tamil Nadu 608002, India

e Polymer Research Unit, Department of Chemistry, Utkal University, Bhubaneswar 751004, India

References (51)

Show source-provided references
1. Kreuter J. · Pharm. Acta Helv. · 1978 · 53 · 33
2. Lambert G. · Adv. Drug Deliv. Rev. · 2001 · 47 · 9910.1016/S0169-409X(00)00116-2 ↗
3. Moghimi S. M. · Crit. Rev. Ther. Drug Carrier Syst. · 1990 · 7 · 188
4. 10.1016/S0168-3659(99)00231-X10.1016/S0168-3659(99)00231-X ↗
5. Torchilin V. P. · J. Microencapsul. · 1998 · 15 · 210.3109/02652049809006831 ↗
6. 10.1126/science.813483510.1126/science.8134835 ↗
7. 10.1002/app.2703410.1002/app.27034 ↗
8. 10.1002/app.2708910.1002/app.27089 ↗
9. Tanaka T. · Phys. Rev. Lett. · 1978 · 40 · 82110.1103/PhysRevLett.40.820 ↗
10. 10.1063/1.45326710.1063/1.453267 ↗
11. 10.1021/ma00189a02110.1021/ma00189a021 ↗
12. 10.1038/355242a010.1038/355242a0 ↗
13. 10.1126/science.269.5223.52510.1126/science.269.5223.525 ↗
14. 10.1038/3020510.1038/30205 ↗
15. 10.1163/156856293X0019510.1163/156856293X00195 ↗
16. Qiu Y. · Adv. Drug Deliv. Rev. · 2001 · 53 · 322
17. Bae Y. H. · Pharm. Res. · 1991 · 8 · 62410.1023/A:1015860824953 ↗
18. 10.1016/0168-3659(87)90083-610.1016/0168-3659(87)90083-6 ↗
19. Bae Y. H. · J. Control. Rel. · 1992 · 22 · 9510.1016/0168-3659(92)90194-V ↗
20. 10.1016/S0927-7765(99)00080-610.1016/S0927-7765(99)00080-6 ↗
21. 10.3109/1061186000899685510.3109/10611860008996855 ↗
22. Shin Y. · J. Control. Rel. · 2001 · 73 · 110.1016/S0168-3659(01)00247-4 ↗
23. 10.1016/S0169-409X(01)00245-910.1016/S0169-409X(01)00245-9 ↗
24. 10.1208/aapsj090201510.1208/aapsj0902015 ↗
25. Missirlis D. · Eur. J. Pharm. Sci. · 2006 · 29 · 12010.1016/j.ejps.2006.06.003 ↗
26. 10.1109/TNB.2003.82027710.1109/TNB.2003.820277 ↗
27. Maillard S. · J. Steroid Biochem. Mol. Biol. · 2005 · 94 · 11110.1016/j.jsbmb.2004.12.023 ↗
28. Xu Z. · Int. J. Pharm. · 2005 · 288 · 36110.1016/j.ijpharm.2004.10.009 ↗
29. 10.1158/0008-5472.CAN-04-392110.1158/0008-5472.CAN-04-3921 ↗
30. Jain K. K. · Tech. Cancer Res. Treatment · 2005 · 4 · 40710.1177/153303460500400408 ↗
31. Kaul G. · Pharm. Res. · 22 · 95110.1007/s11095-005-4590-3 ↗
32. Pessi M. A. · Drugs · 1997 · 53 · 59310.2165/00003495-199753040-00005 ↗
33. Lamprecht A. · J. Control. Rel. · 2005 · 104 · 33710.1016/j.jconrel.2005.02.011 ↗
34. Asghar L. F. A. · J. Pharm. Pharm. Sci. · 2006 · 9 · 327
35. 10.1023/A:101103232806410.1023/A:1011032328064 ↗
36. Labianca R. F. · Drugs · 2001 · 61 · 175110.2165/00003495-200161120-00006 ↗
37. van Cutsem E. · Hepatogastroenterology · 1999 · 46 · 709
38. 10.1016/S0928-0987(02)00081-710.1016/S0928-0987(02)00081-7 ↗
39. Cortesi E. · J. Chemother. · 1990 · 2 · 4710.1080/1120009X.1990.11739005 ↗
40. Madajewicz S. · Cancer Res. · 1984 · 44 · 4667
41. O'Connell M. J. · J. Clin. Oncol. · 1997 · 15 · 24610.1200/JCO.1997.15.1.246 ↗
42. Watts P. J. · Int. J. Pharm. · 87 · 21510.1016/0378-5173(92)90245-W ↗
43. Pelton R. H. · Colloids Surf. · 1986 · 20 · 24810.1016/0166-6622(86)80274-8 ↗
44. Zhang H. · Biomaterials · 2002 · 23 · 2762
45. Elvira C. · Biomaterials · 2002 · 23 · 195610.1016/S0142-9612(01)00322-2 ↗
46. Wong D. · J. Control. Rel. · 1997 · 47 · 17410.1016/S0168-3659(97)01633-7 ↗
47. Higuchi T. · J. Pharm. Sci. · 1961 · 61 · 875
48. 10.1002/jps.260052121010.1002/jps.2600521210 ↗
49. 10.1016/0378-5173(83)90064-910.1016/0378-5173(83)90064-9 ↗
50. Peppas N. A. · Pharm. Acta Helv. · 1985 · 60 · 110
51. Nassim M. A. · Int. J. Mol. Med. · 2002 · 10 · 514